Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
PLX4032
.
Show all posts
Showing posts with label
PLX4032
.
Show all posts
Monday, August 30, 2010
Experimental drug PLX4032 holds promise against cancers with faulty BRAF gene....
›
Plexxikon recently announced the publication of data from the Phase 1 clinical trial of PLX4032 (RG7204), confirming that treatmen...
›
Home
View web version
